77 related articles for article (PubMed ID: 16548525)
1. Mechanism of prebeta-HDL formation and activation.
Chau P; Nakamura Y; Fielding CJ; Fielding PE
Biochemistry; 2006 Mar; 45(12):3981-7. PubMed ID: 16548525
[TBL] [Abstract][Full Text] [Related]
2. High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function.
Rao MN; Liu QH; Marmillot P; Seeff LB; Strader DB; Lakshman MR
Metabolism; 2000 Nov; 49(11):1406-10. PubMed ID: 11092502
[TBL] [Abstract][Full Text] [Related]
3. HDL and apolipoprotein A1 (apo A1). Their effects on retardation of lipid deposition in aortic intima.
She MP; Liang P; Huang YD; Cai CB; Ran BF; Wang ZL; Xia RY
Chin Med J (Engl); 1992 May; 105(5):369-73. PubMed ID: 1499365
[TBL] [Abstract][Full Text] [Related]
4. In vitro reverse cholesterol transport from THP-1-derived macrophage-like cells with synthetic HDL particles consisting of proapolipoprotein A1 or apolipoprotein A1 and phosphatidylcholine.
Westman J; Roobol C; Carlson LA; Wülfert E
Scand J Clin Lab Invest; 1995 Feb; 55(1):23-33. PubMed ID: 7624733
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-1 (BMP-1) cleaves human proapolipoprotein A1 and regulates its activation for lipid binding.
Chau P; Fielding PE; Fielding CJ
Biochemistry; 2007 Jul; 46(28):8445-50. PubMed ID: 17580958
[TBL] [Abstract][Full Text] [Related]
6. Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.
Pownall HJ; Hosken BD; Gillard BK; Higgins CL; Lin HY; Massey JB
Biochemistry; 2007 Jun; 46(25):7449-59. PubMed ID: 17530866
[TBL] [Abstract][Full Text] [Related]
7. What is so special about apolipoprotein AI in reverse cholesterol transport?
Curtiss LK; Valenta DT; Hime NJ; Rye KA
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):12-9. PubMed ID: 16269660
[TBL] [Abstract][Full Text] [Related]
8. The endothelial cholesterol efflux is promoted by the high-density lipoprotein anionic peptide factor.
Domingo N; Mastellone I; Grès S; Marin V; Lorec AM; Tosini F; Grosclaude J; Farnarier C; Chanussot F
Metabolism; 2005 Aug; 54(8):1087-94. PubMed ID: 16092060
[TBL] [Abstract][Full Text] [Related]
9. Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution.
Tian L; Wu J; Fu M; Xu Y; Jia L
Metabolism; 2009 May; 58(5):668-74. PubMed ID: 19375590
[TBL] [Abstract][Full Text] [Related]
10. Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients.
von Eckardstein A; Huang Y; Kastelein JJ; Geisel J; Real JT; Kuivenhoven JA; Miccoli R; Noseda G; Assmann G
Atherosclerosis; 1998 May; 138(1):25-34. PubMed ID: 9678768
[TBL] [Abstract][Full Text] [Related]
11. [Over-expression in Escherichia coli and characterization of apolipoprotein AI].
Ding MS; Ma WF; Zhang MF; Liu DT; Guo MJ; Zhuang YP; Chu J; Zhang SL; Gong BQ
Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):198-203. PubMed ID: 16013475
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.
Qin S; Koga T; Ganji SH; Kamanna VS; Kashyap ML
Metabolism; 2008 Jul; 57(7):973-9. PubMed ID: 18555840
[TBL] [Abstract][Full Text] [Related]
13. [Detection of qualitative abnormalities of HDL by measurement of prebeta1-HDL concentration].
Miida T
Rinsho Byori; 2006 Dec; 54(12):1241-6. PubMed ID: 17265898
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of niacin.
Kamanna VS; Kashyap ML
Am J Cardiol; 2008 Apr; 101(8A):20B-26B. PubMed ID: 18375237
[TBL] [Abstract][Full Text] [Related]
15. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
Kypreos KE
Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
[TBL] [Abstract][Full Text] [Related]
16. New model for kinetic studies of HDL metabolism in humans.
Chétiveaux M; Ouguerram K; Zair Y; Maugère P; Falconi I; Nazih H; Krempf M
Eur J Clin Invest; 2004 Apr; 34(4):262-7. PubMed ID: 15086357
[TBL] [Abstract][Full Text] [Related]
17. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
[TBL] [Abstract][Full Text] [Related]
18. Degradation of pre-beta-high density lipoproteins and their binding activity to human blood monocytes.
Nakabayashi T; Yamauchi K; Sugano M; Sano K; Tozuka M; Hidaka H
Ann Clin Lab Sci; 2004; 34(3):287-98. PubMed ID: 15487703
[TBL] [Abstract][Full Text] [Related]
19. Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs.
Briand F; Magot T; Krempf M; Nguyen P; Ouguerram K
Eur J Clin Invest; 2006 Apr; 36(4):224-30. PubMed ID: 16620283
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of prebeta1 HDL and alphaHDL in type II diabetic patients.
Chétiveaux M; Lalanne F; Lambert G; Zair Y; Ouguerram K; Krempf M
Eur J Clin Invest; 2006 Jan; 36(1):29-34. PubMed ID: 16403007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
